APYX · Apyx Medical Corp
$3.85
-0.04 (-1.03%)
At close · Jul 28
Market Cap
$161.63M
Shares
41.87M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$52.84M
+9.9%
FY2025
Net Income
-$11.21M
+52.2%
FY2025
Gross Margin
62.53%
+1.5pp
FY2025
Operating Margin
-12.2%
+27pp
FY2025
Diluted EPS
-$0.54
+19.4%
FY2023
Operating Cash Flow
-$8M
+55.7%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 (G) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $59M – $60M | $55.9M | $52.84M | $48.1M | $52.35M | $44.51M | $48.52M | $27.71M | $28.24M | $16.61M | $10.23M | $8.82M | $29.52M | $27.68M | $23.66M | $27.67M | $25.41M | $24.23M | $26.95M | |
| — | $0 | — | — | — | — | — | — | — | — | -$136K | -$158K | -$158K | -$151K | -$237K | -$232K | -$237K | -$223K | -$52K | |
| — | $20.6M | $19.8M | $18.74M | $18.59M | $15.38M | $14.92M | $10.21M | $9.14M | $5.78M | $3.28M | $3.7M | $16.96M | $18.69M | $14.46M | $16.34M | $14.68M | $14.24M | $15.1M | |
| — | $35.3M | $33.04M | $29.36M | $33.76M | $29.13M | $33.6M | $17.5M | $19.09M | $10.83M | $6.96M | $5.12M | $12.56M | $8.99M | $9.2M | $11.33M | $10.73M | $9.99M | $11.86M | |
| — | — | 62.53% | 61.04% | 64.49% | 65.45% | 69.26% | 63.17% | 67.63% | 65.2% | 67.99% | 58.01% | 42.54% | 32.48% | 38.88% | 40.96% | 42.23% | 41.22% | 43.98% | |
| — | $3.33M | $3.37M | $5.08M | $5.44M | $4.54M | $4.32M | $3.92M | $3.73M | $2.55M | $1.94M | $1.03M | $2.16M | $1.42M | $1.26M | $1.33M | $1.2M | $1.85M | $2.08M | |
| — | $15.91M | $15.8M | $18.86M | $22.2M | $20.48M | $18.62M | $11.69M | $13.7M | $9.41M | $8.69M | $6.19M | $8.42M | $6.69M | $5.78M | $4.34M | $4.35M | $4.89M | $4.66M | |
| — | — | — | — | — | — | — | — | — | $100K | $100K | $100K | $100K | $100K | $88K | $115K | $172K | $273K | $273K | |
| — | — | $655K | $599K | $692K | $890K | $903K | $887K | $754K | $669K | $696K | $734K | $812K | $876K | $827K | $742K | $753K | $734K | $777K | |
| — | $39.61M | $39.49M | $48.21M | $53.7M | $52.69M | $48.05M | $37.59M | $39.96M | $25.1M | $20.84M | $16.51M | $19.54M | $14.84M | — | — | — | — | — | |
| — | -$4.31M | -$6.45M | -$18.85M | -$17.26M | -$23.56M | -$14.45M | -$20.08M | -$20.87M | -$14.28M | -$13.89M | -$11.39M | -$6.99M | -$5.85M | -$3.67M | $1.05M | -$18K | -$2.75M | $715K | |
| — | — | -12.2% | -39.18% | -32.97% | -52.94% | -29.78% | -72.47% | -73.91% | -85.97% | -135.68% | -129.18% | -23.67% | -21.13% | -15.49% | 3.78% | -0.07% | -11.36% | 2.65% | |
| — | — | -$5.79M | -$18.25M | -$16.57M | -$22.67M | -$13.55M | -$19.2M | -$20.12M | -$13.61M | -$13.19M | -$10.66M | -$6.17M | -$4.97M | -$2.84M | $1.79M | $735K | -$2.02M | $1.49M | |
| — | $5.58M | $5.59M | $5.91M | $2.48M | $15K | $10K | $46K | $8000 | $104K | $136K | $158K | — | — | — | — | — | — | — | |
| — | $1.05M | $1.11M | $1.61M | $921K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| — | -$4.41M | -$4.39M | -$4.46M | -$4.02M | $651K | -$372K | $674K | $1.03M | -$415K | $47K | -$94K | $1.64M | -$7.44M | -$2.29M | -$212K | $50K | $290K | -$52K | |
| — | — | — | — | — | — | — | $0 | $164K | $247K | $0 | — | — | — | — | — | — | — | — | |
| — | -$8.71M | -$10.84M | -$23.31M | -$21.28M | -$22.91M | -$14.82M | -$19.41M | -$19.84M | -$14.69M | -$13.84M | -$11.49M | -$5.35M | -$13.29M | -$5.95M | $834K | $32K | -$2.46M | $663K | |
| — | $364K | $270K | $252K | -$2.43M | $367K | $380K | -$7.5M | -$130K | -$3.91M | -$156K | $64K | $25K | $4M | -$1.61M | $217K | $77K | -$927K | $67K | |
| — | -$9.21M | -$11.21M | -$23.46M | -$18.71M | -$23.18M | -$15.17M | -$11.9M | -$19.71M | $62.72M | -$5.06M | -$11.55M | -$5.37M | -$17.28M | -$4.34M | $617K | $109K | -$1.54M | $596K | |
| — | — | -21.22% | -48.78% | -35.75% | -52.09% | -31.27% | -42.93% | -69.79% | 377.71% | -49.46% | -130.97% | -18.19% | -62.43% | -18.34% | 2.23% | 0.43% | -6.34% | 2.21% | |
| — | $93K | $106K | -$96K | -$137K | -$94K | -$28K | -$10K | $0 | — | — | — | — | — | — | — | — | — | — | |
| — | -$9.17M | -$11.21M | -$23.46M | -$18.71M | -$23.18M | — | — | -$19.71M | $62.72M | -$5.06M | -$3.95M | $8.36M | -$18.21M | -$6.99M | $617K | — | — | — | |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | -$1.45M | $595K | |
| USD/shares | — | — | -$0.27 | -$0.66 | -$0.54 | -$0.67 | -$0.44 | -$0.35 | -$0.58 | $1.89 | -$0.16 | -$0.14 | $0.34 | -$1.03 | -$0.40 | $0.04 | $0.01 | -$0.09 | $0.04 |
| USD/shares | — | — | — | — | -$0.54 | -$0.67 | -$0.44 | -$0.35 | -$0.58 | $1.83 | -$0.17 | -$0.15 | $0.24 | -$1.03 | -$0.40 | $0.03 | $0.01 | -$0.09 | $0.03 |
| shares | — | — | 41.1M | 35.54M | 34.62M | 34.52M | 34.33M | 34.21M | 34.07M | 33.19M | 31.42M | 27.43M | 24.33M | 17.76M | 17.76M | 17.63K | 17.6K | 17.37M | 16.9M |
| shares | — | — | — | — | 34.62M | 34.52M | 34.33M | 34.21M | 34.07M | 34.37M | 31.43M | 27.45M | 27.75M | 17.76M | 17.76M | 17.79K | 17.67K | 17.37M | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 1.53×
EV/EBIT
—
Peer median 19.76×
P/E (TTM)
—
Peer median 31.89×
Peer medians compare against the 83 similar-size Medical Devices companies (of 146 listed).
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Surgical Aesthetics | $45,332,000 | $38,606,000 | — | — | — | — | — |
| Oem | $7,512,000 | $9,496,000 | $8,967,000 | $7,707,000 | $5,532,000 | $5,497,000 | $5,559,000 |
| Advanced Energy | — | — | $43,382,000 | $36,803,000 | $42,985,000 | $22,214,000 | $22,676,000 |
By Geography (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| United States | $38,801,000 | $34,022,000 | $38,345,000 | $31,208,000 | $32,980,000 | $18,812,000 | $19,584,000 |
| Non Us | $14,043,000 | $14,080,000 | $14,004,000 | $13,302,000 | $15,537,000 | $8,899,000 | $8,651,000 |
Segment Operating Income
Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Surgical Aesthetics | $6,686,000 | -$3,889,000 | — | — | — | — | — |
| Oem | $1,855,000 | $1,973,000 | $2,524,000 | $1,641,000 | $1,033,000 | $1,838,000 | $2,136,000 |
| Advanced Energy | — | -$3,889,000 | -$956,000 | -$4,103,000 | $2,784,000 | -$7,128,000 | -$8,045,000 |
Operating Margin by Segment (%)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Surgical Aesthetics | 14.7% | -10.1% | — | — | — | — | — |
| Oem | 24.7% | 20.8% | 28.1% | 21.3% | 18.7% | 33.4% | 38.4% |
| Advanced Energy | — | — | -2.2% | -11.1% | 6.5% | -32.1% | -35.5% |